Bio-Techne (TECH) Declares $0.32 Quarterly Dividend; 0.7% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Bio-Techne (TECH) Tops Q2 EPS by 8c, Revenues Beat
February 5, 2019 6:34 AM ESTBio-Techne (NASDAQ: TECH) reported Q2 EPS of $1.06, $0.08 better than the analyst estimate of $0.98. Revenue for the quarter came in at $174.5 million versus the consensus estimate of $170.19 million.
Second quarter organic revenue increased by 11% (13% reported) to $174.5 million.GAAP EPS was $0.45 vs. $1.29 one year ago. Current Year GAAP EPS saw a one-time benefit for tax reform of $0.02 compared to a prior year GAAP EPS benefit of $0.94. Delivered adjusted earnings per share (EPS) of $1.06, an increase of 4% over the prior year. Excellent commercial execution in all major regions, especially China, with organic growth over... More